Tianyin Pharmaceutical Co., Inc. - TPI

Tianyin Pharmaceutical Co., Inc. (TPI)
http://www.tianyinpharma.com
Coverage: October 3, 2009 - October 3, 2010
Featured: October 3, 2009

Latest Newsletter Editions

spacer
Sat, May 22, 2010 @ 02:05 pm
There was a little relief rally on Friday after a fairly wicked week in the markets. Thursday's giant sell down felt like a "cash at any cost" down draft, with almost no regard for value. That's fine with me. These kinds of emotional, momentum driven markets present opportunities for those with the...
Tue, May 18, 2010 @ 10:05 am
A Busy Day- Comments on a Bunch of Stuff Frankly, it's a bit annoying. I wish these smaller companies could get their quarterly numbers out over a few week period in time, instead of all in one or two days at the absolute deadline. I just can't get quality commentary out fast enough for investors to...
Mon, Feb 1, 2010 @ 03:02 pm
Nothing Like a Cool $200 Million You might wonder who's got the cool $200 million, and what it has to do with today's edition of the OTC Journal. Remember my short term trading idea?- TapImmune (OTC BB: TPIV) I said some positive developments would start to roll their way, and today's post close news...
Wed, Jan 27, 2010 @ 09:01 am
Two Beat Downs; Stand By I just wanted to publish a couple of quick notes on two stocks I've been covering and have made comments on recently. First on China Recycling Energy (CREG)- someone is selling the stock fairly ruthlessly with little regard for price. It started two days ago, and the stock is...
Thu, Jan 21, 2010 @ 01:01 pm
How The Immune System Fights Disease Our bodies have a miraculous capability. Our Immune System, through a complex network of cells and chemicals, has the ability to identify bad stuff and rapidly recruit an army to attack foreign invaders and kill them. T-Cells are the circus ring masters. The T-Cells...

Click Here For More Newsletters on TPI

spacer

Latest Blog Entries

spacer

Quote Data

spacer
Last Trade: 0.45 Bid: 0.4300
Last Size: 1,100 Ask: 0.4500
Trade Time: 4:05pm Bid x Ask Size: 4900x5900
Change: down arrow -0.0200 (-4.26%) Day's Range: 0.42 - 0.46
Prev Close: 0.4700 52wk Range: 0.38 - 0.78
Open: 0.4600 P/E (ttm): N/A
Volume: 181,353 EPS (ttm): -0.09
spacer [Chart]

Business Summary

spacer
Tianyin Pharmaceutical Co., Inc. engages in the development, manufacture, marketing, and sale of modernized traditional Chinese medicines and other pharmaceuticals in the People’s Republic of China. The company’s products are intended to address various medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology, and pediatrics. It manufactures a portfolio of 39 modernized traditional Chinese medicines and pharmaceuticals, and has a pipeline of 17 products, which are pending regulatory approvals with the China State Food and Drug Administration. The company was founded in 1994 and is based in Chengdu, the People’s Republic of China.

Disclosure

spacer
The OTC Journal has received no compensation for coverage of Tianyin Pharmaceutical Co., Inc.

Recent News Headlines

spacer
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Thu, 25 Jun 2015 13:52:21 GMT
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,
Mon, 22 Jun 2015 19:08:18 GMT
Buchang to Increase Stake in Tianyin-Buchang Alliance
Mon, 15 Jun 2015 09:22:00 GMT
[PR Newswire] - CHENGDU, China, June 15, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine ...
Tianyin Pharmaceutical Announces Further Updates on Joint Venture with Buchang Pharma
Fri, 12 Jun 2015 08:31:00 GMT
[PR Newswire] - CHENGDU, China, June 12, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine ...
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru
Tue, 26 May 2015 20:15:48 GMT
TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements
Tue, 26 May 2015 17:46:00 GMT
[PR Newswire] - CHENGDU, China, May 26, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), announced that the Company's Annual Meeting of Shareholders for fiscal year ended June 30, 2014 which was scheduled to be held at the Company's office located in Chengdu, China and via conference call, at 9:00 AM (local time in Chengdu, China) on May 25, 2015 (the "Meeting") has been adjourned due to the lack of a quorum at the Meeting. Any shareholders as of the Record Date who have not yet submitted their proxies may still do so prior to the adjourned meeting date.
TPI Holds Annual Meeting of Shareholders on May 25, 2015 at Chengdu, China
Thu, 23 Apr 2015 00:18:00 GMT
[PR Newswire] - CHENGDU, China, April 22, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese ...
TIANYIN PHARMACEUTICAL CO., INC. Financials
Thu, 19 Mar 2015 17:04:22 GMT
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 10-Q, Quarterly Report
Fri, 13 Mar 2015 15:51:31 GMT
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Ru
Thu, 26 Feb 2015 21:30:09 GMT
TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements
Thu, 26 Feb 2015 21:01:00 GMT
[PR Newswire] - CHENGDU, China, Feb. 26, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), received notice on February 24, 2015 from the NYSE MKT LLC (the "Exchange") indicating that the Company is below certain of the Exchange's continued listing standards, as set forth in Sections 134 and 1101 of the NYSE MKT Company Guide, due to the delay in filing of its Quarterly Report on Form 10-Q for the period ended December 31, 2014 (the "Form 10-Q"). Under NYSE MKT rules, until the Company files the Form 10-Q, its common stock will remain listed on the NYSE MKT under the symbol "TPI," but will be assigned an ".LF" indicator to signify late filing status.
JCM Plans for FDA certification Process for International Business Development
Tue, 17 Feb 2015 19:55:00 GMT
[PR Newswire] - CHENGDU, China, Feb. 17, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) updated on the business and development at its Jiangchuan Macrolide Facility (JCM) API operation. In addition to JCM's certification at India, along with other international clients located at Bangladesh, Philippines and Iran on import status, TPI plans for FDA certification process at its JCM facility in order to service international clients such as Pfizer's (www.pfizer.com) and their subsidiaries in China.
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Other Events, Financial Statements and Exhibits
Fri, 06 Feb 2015 17:56:07 GMT
TPI to Form Strategic Alliance with Buchang Pharma
Fri, 06 Feb 2015 15:53:00 GMT
[PR Newswire] - CHENGDU, China, Feb. 6, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine ...
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Change in Directors or Principal Officers
Wed, 28 Jan 2015 21:09:40 GMT
TPI's JCM Updates on Import Registration for International Clients
Fri, 23 Jan 2015 08:03:00 GMT
[PR Newswire] - CHENGDU, China, Jan. 23, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the development and sale of patented biopharmaceutical medicine, ...
TPI QLF Received GMP Certification
Tue, 20 Jan 2015 12:30:00 GMT
[PR Newswire] - CHENGDU, China, Jan. 20, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine ...
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Fri, 16 Jan 2015 16:10:51 GMT
TPI to Form Strategic Alliance with Buchang Pharma
Wed, 14 Jan 2015 16:26:00 GMT
[PR Newswire] - CHENGDU, China, Jan. 14, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine ...
TPI Initiates the Official Relocation Process to Qionglai Tianyin Facility (QLF)
Mon, 12 Jan 2015 16:50:00 GMT
[PR Newswire] - CHENGDU, China, Jan. 12, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine ...